Current Multiple Sclerosis Treatments

With the certain advances in research involving multiple sclerosis, scientists have been able to find some effective treatments for multiple sclerosis. Even though a cure for MS still evades researchers, studies have advanced the knowledge that scientists now have about the disease that will eventually lead to finding the elusive cure. But what current drugs and known treatments there are today help MS patients manage the disease better than before.

Fingolimod

Fingolimod is a drug that has been used to treat relapsing remitting MS, considered as the most common form of the disease. Clinical trials for treatment of progressive MS will also be underway. Fingolimod, or FTY720 binds to lymphocytes and holds them into the lymph nodes. This allows lower T cells circulating in the blood stream and thus helps in reducing inflammation and myelin damage in the central nervous system that is caused by the immune system.

Teriflunomide

Another drug used to treat relapsing remitting MS is teriflunomide. It can also be used to treat patients with secondary progressive MS who are still suffering from relapses. The drug blocks the action of T cells, the immune cells that are known to cause the damage to the brain and the spinal cord of people suffering from MS. Teriflunomide only affects the body’s T cells and leaves the other immune functions intact, giving MS patients some level of immune protection against other pathogens.

Laquinimod

Laquinimod is a relatively new treatment aimed for patients with multiple sclerosis. Although scientists are not yet fully aware of how the drug actually works, clinical studies have shown that it has been very effective in reducing disease activity in people with MS. Researchers believe that the drug has some effect on the body’s immune system.

Cladribine

Cladribine is more known as a drug used for treating leukemia. But since it has been known to affect T cells in the immune system, it has been eyed as a promising treatment also for people with MS. In fact, some studies have indicated that Cladribine may be able to reduce relapse rates and lesions in the brain caused by MS. Cladribine may also aid in slowing down disability progression in people with MS.

Minocycline

Minocycline is a known anti-bacterial drug more commonly used to treat acne, respiratory and urinary infections. But the said drug has also been known to have anti-inflammatory properties that may help in preventing inflammation which can cause damage to the brain and the spinal cord for patients with MS.

 
You can leave a response, or trackback from your own site.